Prolongation of anoxia-induced hyperemia in healthy middle-aged men treated with cinnarizine and flunarizine.
D000328:Adult; D001158:Arteries / Q000502:physiology; D002934:Cinnamates / Q000494:pharmacology; D002986:Clinical Trials as Topic; D005464:Fluorobenzenes / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D006940:Hyperemia / Q000209:etiology* / Q000503:physiopathology; D000860:Hypoxia / Q000150:complications* / Q000503:physiopathology; D007866:Leg / Q000098:blood supply; D008026:Ligation; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000494:pharmacology*; D010919:Placebos; D012039:Regional Blood Flow / Q000187:drug effects; D013933:Thumb / Q000098:blood supply; D013997:Time Factors; D014665:Vasodilator Agents / Q000494:pharmacology*
D002934:Cinnamates; D005464:Fluorobenzenes; D006634:Histamine H1 Antagonists; D010879:Piperazines; D010919:Placebos; D014665:Vasodilator Agents